Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
15687-37-3
Molecular formula
C11H9N3O2
Molecular weight
215.21 g/mol
Drug class
Venotonic and capillary-protective agentflavonoid-related vasoprotective compound
Mechanism of action
Reported to reduce capillary permeability and fragility and to influence venous tone and microcirculatory function. Its precise molecular mechanism and clinical contribution are not fully established.
Indications / reported uses
Historically used for symptoms associated with chronic venous insufficiency and capillary fragility in countries where naftazone is authorised; current availability and evidence vary by jurisdiction.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Naftazone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Naftazone Permitted Daily Exposure (PDE) report (the Naftazone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Naftazone Occupational Exposure Limit (OEL) report (the Naftazone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.